Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 4/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.43 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8316403 | 1.00 | LGALS8 (0.45) | LGALS8PTGS2CYP1A2NFKB1THPO | |
| SCHEMBL7957491 | 0.89 | CYP1A2 (0.43) | LGALS8CYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL7957485 | 0.89 | CYP1A2 (0.43) | LGALS8CYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL7957966 | 0.89 | CYP1A2 (0.46) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL7957970 | 0.89 | CYP1A2 (0.46) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL7656587 | 0.88 | PTGS2 (0.46) | PTGS2ALDH1A1 | |
| SCHEMBL7957336 | 0.88 | PTGS2 (0.46) | PTGS2ALDH1A1 | |
| SCHEMBL7959227 | 0.88 | CYP1A2 (0.45) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL7959226 | 0.88 | CYP1A2 (0.45) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL7958044 | 0.86 | CYP1A2 (0.49) | LGALS8CYP1A2NFKB1THPOALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6271342-B1 | SERUM STABILITY; FOR TUMOR THERAPY | BAYER AKTIENGESELLSCHAFT (DE) | 2001-08-07 | — | — | US | disclosed |
| EP-0819135-B1 | SUGAR-MODIFIED CYTOSTATICS | BAYER AG (DE) | 1999-11-17 | — | — | EP | disclosed |
| CN-1185786-A | Sugar-modified cytostatics | BAYER AG (DE) | 1998-06-24 | — | — | CN | disclosed |